These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 324694)

  • 1. Relationship between blood level of atenolol and pharmacologic effect.
    Amery A; De Plaen JF; Lijnen P; McAinsh J; Reybrouck T
    Clin Pharmacol Ther; 1977 Jun; 21(6):691-9. PubMed ID: 324694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
    De Plaen JF; Amery A; Reybrouck T
    Eur J Clin Pharmacol; 1976 Sep; 10(5):297-303. PubMed ID: 789082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernández-Pieretti O
    Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.
    Marshall AJ; Barritt DW; Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():168-72. PubMed ID: 337271
    [No Abstract]   [Full Text] [Related]  

  • 6. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of atenolol in hypertensive patients.
    Ibrahim MM; Mossallam R
    Circulation; 1981 Aug; 64(2):368-74. PubMed ID: 7249304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J; Pozet N; McAinsh J; Legheand J; Zech P
    Eur J Clin Pharmacol; 1977 Nov; 12(3):175-80. PubMed ID: 590303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
    McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
    Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
    Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
    Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
    Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
    van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclothiazide and atenolol once daily in essential hypertension.
    Pitkäjärvi T
    Ann Clin Res; 1979 Feb; 11(1):1-8. PubMed ID: 378090
    [No Abstract]   [Full Text] [Related]  

  • 16. Once-daily dosing with Atenolol in patients with mild or moderate hypertension.
    Douglas-Jones AP; Cruickshank JM
    Br Med J; 1976 Apr; 1(6016):990-1. PubMed ID: 773494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of once and twice daily atenolol in hypertension.
    Castleden CM; Dathan JR; George CF
    Postgrad Med J; 1977 Nov; 53(625):679-82. PubMed ID: 339214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol and bendrofluazide in hypertension.
    Petrie JC; Galloway DB; Webster J; Simpson WT; Lewis JA
    Br Med J; 1975 Oct; 4(5989):133-5. PubMed ID: 1104047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.